LONG-TERM TESTOSTERONE THERAPY IMPROVES ERECTILE FUNCTION AND REDUCES MORTALITY IN MEN WITH HYPOGONADISM AND TYPE 2 DIABETES - UPDATED RESULTS FROM A REGISTRY STUDY

被引：0

作者：

Saad, F. ^{[1
]}

Haider, A.

Haider, K. S.

Doros, G. ^{[2
]}

Traish, A. ^{[3
]}

机构：

[1] Bayer, Whippany, NJ USA

[2] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA

[3] Boston Univ, Sch Med, Boston, MA 02215 USA

来源：

JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S1 / S1

页数：1

共 50 条

[31] Improved glycaemic control and reduced incidence of myocardial infarctions, strokes, and mortality in men with hypogonadism and type 2 diabetes, with and without long-term testosterone therapy
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
EUROPEAN HEART JOURNAL, 2021, 42 : 2805 - 2805
[32] Long-Term Treatment with Testosterone Leads to Profound Weight Loss in Men with Hypogonadism and Type 2 Diabetes: Update of Real-World Data from a Registry Study
Haider, Ahmad
Haider, Karim S.
Saad, Farid
DIABETES, 2022, 71
[33] Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
Traish, Abdulmaged M.
Haider, Ahmad
Haider, Karim Sultan
Doros, Gheorghe
Saad, Farid
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (05) : 414 - 433
[34] Long-Term Testosterone Therapy Results in Remission of Type 2 Diabetes (T2DM) in 34.3% (61 of 178) Men with Hypogonadism and T2DM in a Real-World Registry Study
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2020, 69
[35] Type 2 diabetes and mortality in hypogonadal men improve upon long-term treatment with injectable Testosterone Undecanoate (TU): a controlled registry study
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
DIABETOLOGIA, 2016, 59 : S184 - S184
[36] Weight loss and improved glycaemic control in 324 men with hypogonadism and type 2 diabetes with and without long-term testosterone therapy: real-world registry data
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
DIABETOLOGIA, 2019, 62 : S353 - S353
[37] Improvements of blood pressure, heart rate, and pulse pressure in men with hypogonadism and type 2 diabetes, with and without long-term testosterone therapy
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
EUROPEAN HEART JOURNAL, 2021, 42 : 2389 - 2389
[38] TIME COURSE OF CHANGES IN ERECTILE FUNCTION IN MEN WITH FUNCTIONAL HYPOGONADISM RECEIVING LONG-TERM TESTOSTERONE THERAPY IN COMPARISON TO AN UNTREATED CONTROL GROUP
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S129 - S129
[39] Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study
Yassin, Aksam
Haider, Ahmad
Haider, Karim S.
Caliber, Monica
Doros, Gheorghe
Saad, Farid
Garvey, W. Timothy
DIABETES CARE, 2019, 42 (06) : 1104 - 1111
[40] LONG-TERM TESTOSTERONE TREATMENT IMPROVES URINARY AND SEXUAL FUNCTION IN HYPOGONADAL MEN - RESULTS FROM A PROPENSITY-MATCHED SUBGROUP OF A CONTROLLED REGISTRY STUDY
Saad, F.
Haider, A.
Haider, K. S.
Doros, G.
Traish, A.
JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E8 - E8

← 1 2 3 4 5 →